Thomas Michael Marti

Has grant

University Hospital of Bern

Switzerland

Research Interests

Explore related searches

Professors in Switzerland Professors in Immunology Immunology professors in Switzerland

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Open

Repurposing of the anti-epileptic drug stiripentol for cancer therapy

Open Date: 2025-03-01

Close Date: 2028-02-01

Grant: Open

Modulate cellular plasticity and lactate metabolism to augment lung cancer therapy

Open Date: 2023-03-01

Close Date: 2027-02-28

Grant: Close

Involvement of the lactate dehydrogenase LDHB in lung cancer tumour initiation and therapy resistance

Open Date: 2022-03-01

Close Date: 2025-02-28

Grant: Close

Targeting tumour initiating cells in lung cancer

Open Date: 2018-03-01

Close Date: 2021-02-28

Grant: Close

Role of PP2A phosphatase and miR-19b in DNA damage response and temozolomide / radiotherapy resistance of glioblastoma tumours

Open Date: 2018-03-01

Close Date: 2022-02-28

Articles (10)

Year:

2025

Year:

2025

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (4)

Ren-Wang Peng

Professor

SWITZERLAND

View details

Gregor J Kocher

SWITZERLAND

View details

Shunqing Liang

Assistant Professor

University of Minnesota

UNITED STATES

View details

Ralph Alexander Schmid

Full Prof./Scientific Director

University of Calabria

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Thomas Michael Marti

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (10)

Inhibition of LDHB triggers DNA damage and increases cisplatin sensitivity in pleural mesothelioma

Pro-Inflammatory Properties of Salivary Gland-Derived Fibroblasts—Implications in Sjögren’s Disease

Dissecting the Immunological Profiles in NSD3-Amplified LUSC through Integrative Multi-Scale Analyses

Schedule-Dependent Treatment Increases Chemotherapy Efficacy in Malignant Pleural Mesothelioma

CRISPR-mediated kinome editing prioritizes a synergistic combination therapy for FGFR1-amplified lung cancer

Chemotherapy-induced CDA expression renders resistant non-small cell lung cancer cells sensitive to 5'-deoxy-5-fluorocytidine (5'-DFCR).

CRISPR Screening Identifies WEE1 as a Combination Target for Standard Chemotherapy in Malignant Pleural Mesothelioma

CD90+CD146+ identifies a pulmonary mesenchymal cell subtype with both immune modulatory and perivascular-like function in postnatal human lung.

Beyond DNA Repair: DNA-PKcs in Tumor Metastasis, Metabolism and Immunity

Pharmacotranscriptomic Analysis Reveals Novel Drugs and Gene Networks Regulating Ferroptosis in Cancer

Collaborators (4)

Ren-Wang Peng

Gregor J Kocher

Shunqing Liang

Ralph Alexander Schmid

Make your next move.